Entyvio 300 MG vials

Ended Awarded

Contract number
SPE2DR26FHLJ7
Awardee
Awarding agency
Obligated
$49,663

Award facts

Contract value 100% obligated
$49,662.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Logistics Agency issued a $49,662.50 delivery order to DMS Pharmaceutical Group Inc. on June 23, 2026, for Entyvio 300 mg vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

DMS Pharmaceutical is a woman-owned small business and the sole regional prime vendor under PPV-G GEN V, holding a single-award indefinite delivery contract (SPE2DX) with a $499.999 billion ceiling through December 31, 2036. Place of performance is Park Ridge, Illinois. The order ultimate completion date is June 24, 2026, with firm fixed-price terms and no set-aside designation.

Quick answers

Who was awarded contract SPE2DR26FHLJ7?

SPE2DR26FHLJ7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 23, 2026.

How much is contract SPE2DR26FHLJ7 worth?

The government has obligated $49,663 on SPE2DR26FHLJ7.

Is contract SPE2DR26FHLJ7 an order under another contract?

Yes. SPE2DR26FHLJ7 is a delivery order under SPE2DR25D9222, an indefinite delivery contract.

Was contract SPE2DR26FHLJ7 competed?

The extent of competition for SPE2DR26FHLJ7 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login